A 7-laboratory study to calibrate antimicrobial susceptibility testing methods and breakpoints against EUCAST reference standards for bedaquiline, clofazimine, levofloxacin, and linezolid
Identificatie van nieuwe resistentiemechanismen voor fluoroquinolonen en clofazimine bij Mycobacterium tuberculosis
Emergence of canonical and noncanonical genomic variants following in vitro exposure of clinical Mycobacterium tuberculosis strains to bedaquiline or clofazimine
Optimization of the clofazimine structure leads to a highly water-soluble C3-aminopyridinyl riminophenazine endowed with improved anti-Wnt and anti-cancer activity in vitro and in vivo
Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline